CLINICAL_TRIALS trial_result · 2012-01-20

Clinical Trial Update: Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) [Phase 4]

Phase 4 clinical trial assessing sitagliptin treatment in patients with type 2 diabetes during Ramadan completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: COMPLETED | Results posted: 2012-01-20